Eukaryotic translation initiation factors and cancer.

Abstract

Recent technological advancements have shown tremendous mechanistic accomplishments in our understanding of the mechanism of messenger RNA translation in eukaryotic cells. Eukaryotic messenger RNA translation is very complex process that includes four phases (initiation, elongation, termination, and ribosome recycling) and diverse mechanisms involving protein and non-protein molecules. Translation regulation is principally achieved during initiation step of translation, which is organized by multiple eukaryotic translation initiation factors. Eukaryotic translation initiation factor proteins help in stabilizing the formation of the functional ribosome around the start codon and provide regulatory mechanisms in translation initiation. Dysregulated messenger RNA translation is a common feature of tumorigenesis. Various oncogenic and tumor suppressive genes affect/are affected by the translation machinery, making the components of the translation apparatus promising therapeutic targets for the novel anticancer drug. This review provides details on the role of eukaryotic translation initiation factors in messenger RNA translation initiation, their contribution to onset and progression of tumor, and how dysregulated eukaryotic translation initiation factors can be used as a target to treat carcinogenesis.

• Authors: Muhammad Umar Ali, Muhammad Saif Ur Rahman, Zhenyu Jia, Cao Jiang
• Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (Tumour Biol) Vol. 39 Issue 6 Pg. 1010428317709805 (Jun 2017) ISSN: 1423-0380 [Electronic] Netherlands
• PMID: 28653885 (Publication Type: Journal Article)

Chemical References

• Codon, Initiator
• Eukaryotic Initiation Factors

Topics

• Carcinogenesis
• Codon, Initiator (genetics)
• Eukaryotic Initiation Factors (genetics)
• Gene Expression Regulation
• Humans
• Neoplasms (drug therapy, genetics, pathology)
• Protein Biosynthesis
• Ribosomes (genetics)